The Glioma clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Glioma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026- DelveInsight’s
The ANCA Vasculitis clinical trial analysis report delivers important insights into ongoing research of 12+ pipeline ANCA Vasculitis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10,
The PH-ILD clinical trial analysis report delivers important insights into ongoing research on multiple pipeline PH-ILD drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s
The Chronic Obstructive Pulmonary Disease clinical trial analysis report delivers important insights into ongoing research of 65+ pipeline Chronic Obstructive Pulmonary Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
The Key Eosinophilic Esophagitis Companies in the market include – Sanofi/Regeneron Pharmaceuticals, Dr. Falk Pharma GmbH, AstraZeneca and Amgen, Ellodi Pharmaceuticals, Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical,
The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB
The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life Sciences, Roche, Annovis Bio, and others . The Alzheimer’s Disease
The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK
(Las Vegas, Nevada, United States) – September 10, 2026: As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key companies continuously working towards developing 200 + Non-Hodgkin Lymphoma treatment
The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals,
The Key Multiple Myeloma Companies in the market include – Regeneron Pharmaceuticals, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb, Carsgen Therapeutics, Cartesian Therapeutics, Gracell Biotechnology Shanghai Co., Ltd., CASI Pharmaceuticals, Sorrento
The Key Type 2 Diabetes Companies in the market include – Eli Lilly and Company, Regor Pharmaceuticals Inc., AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova, Sparrow Pharmaceuticals, HighTide
The Key Epidermal growth factor receptor-Non Small Cell Lung Cancer Companies in the market include – AstraZeneca, J&J Innovative Medicine, Hansoh Pharmaceutical, Cullinan Oncology/Taiho Pharmaceutical, Abbvie, Yuhan Corporation, Janssen Research
The Key Obesity Companies in the market include – Rhythm Pharma, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA
DelveInsight’s latest report, “Pertussis – Market Insight, Epidemiology and Market Forecast – 2036,” provides a comprehensive assessment of the global Pertussis market, covering the United States, EU4 (Germany, France, Italy,
DelveInsight’s latest report, “Triple Negative Breast Cancer Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Triple Negative Breast Cancer (TNBC) market across the United
DelveInsight’s latest report, “Malignant Pleural Effusion Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Malignant Pleural Effusion (MPE) market across the United States, EU4
The Shingles clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline Shingles drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s
The Graft versus host disease (GVHD) clinical trial analysis report delivers important insights into ongoing research of 50+ pipeline GVHD drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)
Interstitial Lung Disease, also known as diffuse parenchymal lung disease, represents a heterogeneous group of lung disorders characterized by shared clinical, radiographic, physiologic, or pathologic features, with inflammatory and fibrotic
